Patients transitioning to at-home subcutaneous injections or infusions may experience fear and anxiety, complex administration management and ongoing access challenges. BrightInsight's Disease Management Solution can be easily configured with our SubQ module to ease the patient journey and increase adherence while collecting real-world data on conversion, retention and reasons for drop-off.
Our Disease Management Solution can be configured with a SubQ module that includes a comprehensive, configurable set of features to address unmet needs of patients on subcutaneous therapy.
See how our Disease Management Solution can be easily configured with a SubQ module to support patients using at-home subcutaneous injections.
Read NowWe partnered with Claritas Rx to review 85 brands and patient journeys in a variety of therapy areas to examine why patients stop–or never start–specialty drug therapies and recommend digital strategies to improve conversion.
Read NowRead how the Hizentra app, built on the BrightInsight® Platform, gained high user adoption and an 89% retention rate from 90 days to 12 months.
Read Now